The molecular classification of breast cancer is primarily based on the expression of hormonal receptors, HER2 protein status, and the degree of expression of the Ki67 cell proliferation index, and allows for more precisely tailored therapy to fit the individual characteristics of a tumour [2]. This evidence concerns the gene MKI67 and breast cancer.